Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 11, 2009, Pages 1811-1817

  Mielniczuk, Lisa M ^a   Pfeffer, Marc A ^b   Lewis, Eldrin F ^b   Blazing, Michael A ^c   De Lemos, James A ^d   Mohanavelu, Satishkumar ^b   Rouleau, Jean ^e   Fox, Keith ^f   Pedersen, Terje R ^g   Califf, Robert M ^c  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SIMVASTATIN; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY INTERVENTION; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; ST SEGMENT ELEVATION;

EID: 73449125865     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03510509     Document Type: Article

References (26)

1. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG: Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 113: 2713-2723, 2006
2. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Knudtson M: The association among renal insufficiency, pharmacotherapy and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44: 1587-1592, 2004
3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004
4. Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moye LA, Pfeffer MA, Solomon SD: Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: The Survival And Ventricular Enlargement (SAVE) study. Circulation 110: 3667-3673, 2004
5. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E, TIMI Study Group: Association of glomerular filtration rate on presentation with subsequent mortality in non-ST segment elevation acute coronary syndrome: Observations in 13,307 patients in five TIMI trials. Eur Heart J 22: 1998-2005, 2004
6. Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, deLemos JA, Shui A, Mohanavelu S, Califf RM, Braunwald E: Estimated glomerular filtration rate, inflammation and cardiovascular events after an acute coronary syndrome. Am Heart J 155: 725-731, 2008
7. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ: Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113: 671-678, 2006
8. Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, Petersen R, Peterson ED: Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 113: 1063-1070, 2006
9. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholtz HM: Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 168: 987-995, 2008
10. Hobson, Yavas S, Segal M, Schold J, Triblle C, Layon J, Bihorac. Acute kidney injury is associated with increased long term mortality after cardiothoracic surger. Circulation 119: 2444-2453
11. Lassnigg A, Schmidlin D, Mouhieddine M, Bachman LM, Druml W, Bauer P, Hiesmayer M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol 15: 1597-1605, 2004
12. Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD: Increase in creatinine a and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 17: 2886-2891, 2006
13. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI: Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure. Am J Cardiol 85: 1110-1113, 2000
14. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie DM, Rich MW, Stevenson LW, Young JB, Krumholz HF: Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43: 61-67, 2004
15. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D: C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int 63: 654-661, 2003
16. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M: Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: Analysis of a previously conducted randomised trial. BMJ 332: 1426-1431, 2006
17. Blazing MA, DeLemos JA, Dyke CK, Califf RM, Bilheimer D, Braunwald E: The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy. Am Heart J 142: 211-217, 2001
18. de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, Rouleau JL, Pedersen TR, Gardner LH, Mukherjee R, Ramsey KE, Palmisano J, Bilheimer DW, Pfeffer MA, Califf RM, Braunwald E: A to Z Investigators. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA 292: 1307-1316, 2004
19. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Ann Intern Med 139: 137-147, 2003
20. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM: The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8: 136-141, 2002
21. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53: 597-599, 2009
22. Price JF, Mott AR, Dicerson HA, Jeffereies JL, Nelson DP, Chang AC, O'Brian Smith E, Towbin GA, Dreyer WJ, Denfield SW, Goldstein SL: Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med 9: 343-344, 2008
23. Bellomo R, Ronco, Kellum JA, Mehta RL, Palevsky RL and the ADQI workgroup: Acute renal failure: Definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative (ADQI) group. Critical Care 8: R204-R212. 2004
24. KleinL, Massie B, Leimberger J, O'Connor M, Pina I, Adams K: Califf R, Gheeorghiade M, for the OPTIME Investigators: Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: Results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) Circ Heart Fail 1: 15-33, 2008
25. Stevens LA, Coresh J, Green T, Levey AS: Assesing kidney function: Measured and estimated glomerular filtration rate. N Engl J Med 354: 2473-2478, 2006
26. Morrow DA, deLemos JA, Blazing MA, Sabatine MS, Murphy SA, Jarolim P, White HD, Fox KA, Califf RM, Braunwald E; A to Z Investigators: Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 294: 2866-2890, 2005